Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Inhibition of suppressor T lymphocytes by murine interferon beta.

Literature DB >> 2960771

Inhibition of suppressor T lymphocytes by murine interferon beta.

Abstract

We have presented data showing that IFN-beta at 1,000 U/mouse i.v. inhibits the generation of Ts-mediated tolerance to dinitrofluorobenzene (DNFB) and abrogates the transfer of suppression by Ts. We have also presented data showing that IFN-beta up to 10,000 U/mouse i.v. has no adverse effect on sensitization and elicitation. IFN-beta appears to be a suitable agent for evaluation as an adjunct in the immunotherapy of Ts inducing tumors.

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 1987 PMID： 2960771 PMCID： PMC2189656 DOI： 10.1084/jem.166.5.1573

Source DB: PubMed Journal: J Exp Med ISSN： 0022-1007 Impact factor: 14.307

10 in total

1. Regulation of lymphocyte mitogenesis by (2'--5') oligo-isoadenylate.

Authors: A Kimchi; H Shure; M Revel
Journal: Nature Date: 1979 Dec 20-27 Impact factor: 49.962

2. Adoptive immunization against an established tumor with cytolytic versus memory T cells. Immediate versus delayed onset of regression.

Authors: E S Dye; R J North
Journal: Transplantation Date: 1984-06 Impact factor: 4.939

Review 3. Control of experimental contact sensitivity.

Authors: H N Claman; S D Miller; P J Conlon; J W Moorhead
Journal: Adv Immunol Date: 1980 Impact factor: 3.543

4. Hapten-specific T-cell responses to 4-hydroxy-3-nitrophenyl acetyl. II. Demonstration of idiotypic determinants on suppressor T cells.

Authors: J Z Weinberger; R N Germain; S T Ju; M I Greene; B Benacerraf; M E Dorf
Journal: J Exp Med Date: 1979-10-01 Impact factor: 14.307

5. Inhibition of the T suppressor circuit of delayed-type hypersensitivity by interferon.

Authors: J Knop; R Stremmer; U Taborski; W Freitag; J de Maeyer-Guignard; E Macher
Journal: J Immunol Date: 1984-11 Impact factor: 5.422

6. T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor.

Authors: M J Berendt; R J North
Journal: J Exp Med Date: 1980-01-01 Impact factor: 14.307

7. Inhibition of suppressor T lymphocytes (Ts) by cimetidine.

Authors: D M Sahasrabudhe; C S McCune; R W O'Donnell; E C Henshaw
Journal: J Immunol Date: 1987-05-01 Impact factor: 5.422

8. Immune suppression with supraoptimal doses of antigen in contact sensitivity. I. Demonstration of suppressor cells and their sensitivity to cyclophosphamide.

Authors: M S Sy; S D Miller; H N Claman
Journal: J Immunol Date: 1977-07 Impact factor: 5.422

9. Suppressor T lymphocytes control the development of primary skin cancers in ultraviolet-irradiated mice.

Authors: M S Fisher; M L Kripke
Journal: Science Date: 1982-06-04 Impact factor: 47.728

10. T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases.

Authors: E S Dye; R J North
Journal: J Exp Med Date: 1981-10-01 Impact factor: 14.307

10 in total

5 in total

Inhibition of suppressor T lymphocytes by murine interferon beta.

1. Regulation of lymphocyte mitogenesis by (2'--5') oligo-isoadenylate.

2. Adoptive immunization against an established tumor with cytolytic versus memory T cells. Immediate versus delayed onset of regression.

Review 3. Control of experimental contact sensitivity.

4. Hapten-specific T-cell responses to 4-hydroxy-3-nitrophenyl acetyl. II. Demonstration of idiotypic determinants on suppressor T cells.

5. Inhibition of the T suppressor circuit of delayed-type hypersensitivity by interferon.

6. T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor.

7. Inhibition of suppressor T lymphocytes (Ts) by cimetidine.

8. Immune suppression with supraoptimal doses of antigen in contact sensitivity. I. Demonstration of suppressor cells and their sensitivity to cyclophosphamide.

9. Suppressor T lymphocytes control the development of primary skin cancers in ultraviolet-irradiated mice.

10. T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases.

1. Interferon-alpha/beta inhibits IgE-dependent histamine release from rat mast cells.

2. An attenuated variant of Coxsackievirus B3 preferentially induces immunoregulatory T cells in vivo.

3. Role of beta interferon in resistance to Toxoplasma gondii infection.

4. Disruption of murine cardiac allograft acceptance by latent cytomegalovirus.

5. Effect of murine interferon alpha/beta on tumour-induced suppressor function.